Literature DB >> 29178470

Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis.

E Brisse1, M Imbrechts1, T Mitera1, J Vandenhaute1, N Berghmans2, L Boon3, C Wouters4, R Snoeck5, G Andrei5, P Matthys1.   

Abstract

Haemophagocytic lymphohistiocytosis (HLH) constitutes a spectrum of immunological disorders characterized by uncontrolled immune activation and key symptoms such as fever, splenomegaly, pancytopenia, haemophagocytosis, hyperferritinaemia and hepatitis. In genetic or primary HLH, hyperactivated CD8+ T cells are the main drivers of pathology. However, in acquired secondary HLH, the role of lymphocytes remains vague. In the present study the involvement of lymphocytes in the pathogenesis of a cytomegalovirus-induced model of secondary HLH was explored. We have previously reported CD8+ T cells to be redundant in this model, and therefore focused on CD4+ helper and regulatory T cells. CD4+ T cells were activated markedly and skewed towards a proinflammatory T helper type 1 transcription profile in mice displaying a severe and complete HLH phenotype. Counter to expectations, regulatory T cells were not reduced in numbers and were, in fact, more activated. Therapeutic strategies targeting CD25high hyperactivated T cells were ineffective to alleviate disease, indicating that T cell hyperactivation is not a pathogenic factor in cytomegalovirus-induced murine HLH. Moreover, even though T cells were essential in controlling viral proliferation, CD4+ T cells, in addition to CD8+ T cells, were dispensable in the development of the HLH-like syndrome. In fact, no T or B cells were required for induction and propagation of HLH disease, as evidenced by the occurrence of cytomegalovirus-associated HLH in severe combined immunodeficient (SCID) mice. These data suggest that lymphocyte-independent mechanisms can underlie virus-associated secondary HLH, accentuating a clear distinction with primary HLH.
© 2017 British Society for Immunology.

Entities:  

Keywords:  T cells; haemophagocytic lymphohistiocytosis; macrophage activation syndrome; mouse cytomegalovirus; mouse model

Mesh:

Substances:

Year:  2018        PMID: 29178470      PMCID: PMC6398522          DOI: 10.1111/cei.13084

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

1.  Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis.

Authors:  Maren Tomaske; Oliver Amon; Axel Bosk; Rupert Handgretinger; E Marion Schneider; Dietrich Niethammer
Journal:  Med Pediatr Oncol       Date:  2002-02

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Functional and immunological analysis of recombinant mouse H- and L-ferritins from Escherichia coli.

Authors:  P Santambrogio; A Cozzi; S Levi; E Rovida; F Magni; A Albertini; P Arosio
Journal:  Protein Expr Purif       Date:  2000-06       Impact factor: 1.650

Review 4.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

5.  Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells".

Authors:  Leigh A Stephens; Stephen M Anderton
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

Review 6.  Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives.

Authors:  James W Verbsky; William J Grossman
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

7.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death.

Authors:  William J Grossman; James W Verbsky; Winfried Barchet; Marco Colonna; John P Atkinson; Timothy J Ley
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

8.  Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.

Authors:  An D Billiau; Tania Roskams; Rita Van Damme-Lombaerts; Patrick Matthys; Carine Wouters
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

9.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

Authors:  Michael B Jordan; David Hildeman; John Kappler; Philippa Marrack
Journal:  Blood       Date:  2004-04-06       Impact factor: 22.113

Review 10.  Hemophagocytic syndromes and infection.

Authors:  D N Fisman
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

View more
  1 in total

1.  Genetic Deficiency of Interferon-γ Reveals Interferon-γ-Independent Manifestations of Murine Hemophagocytic Lymphohistiocytosis.

Authors:  Thomas N Burn; Lehn Weaver; Julia E Rood; Niansheng Chu; Aaron Bodansky; Portia A Kreiger; Edward M Behrens
Journal:  Arthritis Rheumatol       Date:  2019-12-15       Impact factor: 10.995

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.